Valuation: GRAIL, Inc.

Market Cap 3.55B 3.04B 2.85B 2.6B 4.91B 340B 4.97B 33.7B 13.11B 171B 13.34B 13.05B 565B P/E 2026 *
-7.93x
P/E 2027 * -7.48x
Enterprise Value 2.94B 2.52B 2.36B 2.16B 4.07B 282B 4.11B 27.93B 10.86B 142B 11.05B 10.81B 468B EV / Sales 2026 *
16.3x
EV / Sales 2027 * 14.2x
Free-Float
94.98%
Yield 2026 *
-
Yield 2027 * -
1 day-3.31%
1 week+10.62%
Current month+12.86%
1 month+14.06%
3 months+12.21%
6 months+53.68%
Current year-9.59%
1 week 68.01
Extreme 68.0101
81.87
1 month 60.76
Extreme 60.76
81.87
Current year 41.5
Extreme 41.5
118.84
1 year 30.82
Extreme 30.82
118.84
3 years 12.33
Extreme 12.33
118.84
5 years 12.33
Extreme 12.33
118.84
10 years 12.33
Extreme 12.33
118.84
Manager TitleAgeSince
Chief Executive Officer 62 2026-05-31
Director of Finance/CFO 47 2021-10-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2026-03-11
Director/Board Member 58 2024-06-20
Director/Board Member 66 2024-06-20
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Director

276 0.0006%
7/15/26 Free

Chairman

427 0.0010%
7/15/26 Free

Director

268 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
-3.31%+10.62%+135.02% - 3.55B
-0.74%+3.78%+2.62%+23.10% 51.61B
+0.01%-0.93%+488.79%+560.03% 44.89B
-0.18%+7.32%+37.70%+20.14% 42.77B
-0.59%+2.58%+20.49%+86.97% 42.58B
+0.88%-3.48%+17.20%+57.20% 31.82B
-0.82%+2.98%+31.73%+143.22% 17.33B
-0.59%+1.66% - - 16.63B
+0.58%+4.66%+9.77%+30.87% 14.76B
-0.66%+2.52%+79.06%+47.95% 14.09B
Average -0.58%+6.07%+91.37%+121.18% 28B
Weighted average by Cap. -0.36%+5.28%+104.02%+139.82%

Financials

2026 *2027 *
Net sales 181M 155M 145M 133M 250M 17.33B 253M 1.72B 668M 8.7B 679M 665M 28.79B 227M 194M 182M 166M 314M 21.72B 317M 2.15B 837M 10.91B 852M 833M 36.09B
Net income -427M -366M -343M -313M -591M -40.92B -597M -4.05B -1.58B -20.55B -1.6B -1.57B -67.99B -465M -399M -373M -341M -643M -44.54B -650M -4.41B -1.72B -22.36B -1.75B -1.71B -73.99B
Net Debt -609M -522M -488M -446M -843M -58.33B -852M -5.78B -2.25B -29.29B -2.29B -2.24B -96.91B -331M -284M -266M -243M -458M -31.71B -463M -3.14B -1.22B -15.92B -1.24B -1.22B -52.69B
Logo GRAIL, Inc.
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.
Employees
910
Date Price Change Volume
26-08-24 US$77.42 -2.67% 155,308
26-08-21 US$79.54 +2.01% 605,055
26-08-20 US$77.97 +5.42% 1,349,618
26-08-19 US$73.96 +4.33% 1,098,199
26-08-18 US$70.89 +1.34% 533,097
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
79.54USD
Average target price
72.38USD
Spread / Average Target
-9.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GRAL Stock